Class Action Lawsuit News
Stay updated on class action lawsuits with press releases highlighting legal news, trends, and developments shaping collective legal actions. Explore opportunities in litigation, legal advocacy, and public interest law.
Apr 17, 2025 at 9:55 PM
Labaton Keller Sucharow LLP Files Securities Class Action Lawsuit Against AppLovin Corporation and Certain of Its Executives
NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) announces that, on April 17, 2025, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client Wayne County Employees’ Retirement System (“Wayne County”) against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) and certain AppLovin executives (collectively, “Defendants”). This action, which is captioned Wayne County Employees’ Retirement System v. AppLovin Corporation, No. 25-cv-03438 (N....
Apr 17, 2025 at 6:44 PM
Rosen Law Firm Encourages UnitedHealth Group Incorporated Investors to Inquire About Securities Class Action Investigation – UNH
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of UnitedHealth Group Incorporated (NYSE: UNH) resulting from allegations that UnitedHealth may have issued materially misleading business information to the investing public. So What: If you purchased UnitedHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen...
Apr 17, 2025 at 3:44 PM
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ibotta, Inc. – IBTA
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Ibotta, Inc. (NYSE: IBTA) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO”). The lawsuit seeks to recover damages for Ibotta investors under the federal securities laws. To join...
Apr 17, 2025 at 12:57 PM
RH BREAKING NEWS: RH’s 60% Stock Drop Triggers Securities Fraud Investigation; Contact BFA Law about how to Potentially Recover Investment Losses
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RH (NYSE: RH) for potential violations of the federal securities laws. If you invested in RH, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/rh. Why is RH being Investigated? RH is a retailer and luxury lifestyle brand operating primarily in the home furnishings market that offers merchandise assortments across a numbe...
Apr 17, 2025 at 12:42 PM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO) and reminds investors of the June 16, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm...
Apr 17, 2025 at 12:00 PM
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the “Class Period”). Treace Medical investors have until June 10, 2025 to file a lead plaintiff motion. IF YOU SUFFERED...
Apr 17, 2025 at 12:00 PM
Deadline Soon: Venture Global, Inc. (VG) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming April 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Venture Global, Inc. (“Venture” or the “Company”) (NYSE: VG) securities pursuant and/or traceable to the Company’s January 2025 initial public offering (“IPO”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON VENTURE GLOBAL, INC. (VG), CLICK HERE TO PARTICIPATE I...
Apr 17, 2025 at 11:39 AM
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of iCAD, Inc. (NasdaqCM: ICAD) to RadNet, Inc. (NasdaqGM: RDNT). Under the terms of the proposed transaction, shareholders of iCAD will receive 0.0677 shares of RadNet for each share of iCAD that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequat...
Apr 17, 2025 at 9:10 AM
ZBIO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Zenas BioPharma business and prospects, resulting in its stock trading at inflated prices....
Apr 16, 2025 at 8:00 PM
Kirby McInerney LLP Urges Investors in Maravai Lifesciences Holdings, Inc. to Inquire About Their Rights in Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 2025 (“the Class Period”). Investors have until May 5, 2025, to apply to the Court to be appointed as lead plaintiff in the la...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.